Event Brief
Novartis cholesterol drug failure raises doubts in race
By The BriefBrief · Sources (1)
Filed: Sep 08, 2026 at 2:07 AM ET
Summary: Novartis’ failure in a cholesterol drug effort has cast doubt on the multibillion-dollar race to lower Lp(a) levels and reduce heart attacks and strokes. The setback increases pressure on Amgen and Eli Lilly as they compete to translate Lp(a) reduction into fewer cardiovascular events.
WHO: Novartis
WHAT: Novartis’ cholesterol drug effort failed, casting doubt on the Lp(a)-lowering race.
WHEN: Sep 08, 2026 at 1:00 AM ET
WHERE: Location not specified
WHY: Cause not yet established.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
ТАСС: ВСУ на правобережье Днепра не наступают
Тасс
Sep 08, 2026 at 2:07 AM ET
🔒
North Korea and Russia open first road bridge
Asia-Pacific
Sep 08, 2026 at 2:07 AM ET
🔒
Man arrested after lunging at Ohio governor candidate
Amy Acton
Sep 08, 2026 at 2:07 AM ET
🔒
Сергей Страмоус освобожден от должности замглавы Росавиации
Сергей Страмоус
Sep 08, 2026 at 2:05 AM ET
🔒
